Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-10 Sale |
2024-12-12 8:26 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
2,817 | $30.79 | $86,735 | 38,335 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:24 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
7,855 | $30.79 | $241,855 | 597,562 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 7:36 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $32.09 | $802,250 | 716,446 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 7:34 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $32.13 | $321,310 | 266,286 (Indirect Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 9:57 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $27.73 | $251,274 | 127,579 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 5:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $35.19 | $351,890 | 91,007 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 09:04 am |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
50,716 | $31.57 | $1,601,252 | 276,286 (Indirect Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 09:00 am |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $31.73 | $3,438,312 | 904,561 (Direct) |
View |
| 2024-10-30 Sale |
2024-11-01 8:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $32.6 | $651,960 | 173,205 (Direct) |
View |
| 2024-10-16 Sale |
2024-10-18 8:57 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $31.41 | $2,878,038 | 1,016,725 (Direct) |
View |
| 2024-10-14 Sale |
2024-10-16 8:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $30.15 | $1,206,080 | 327,002 (Indirect Direct) |
View |
| 2024-10-14 Sale |
2024-10-16 8:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,961 | $30.37 | $636,490 | 114,897 (Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 8:09 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.18 | $281,770 | 286,286 (Indirect Direct) |
View |
| 2024-09-20 Sale |
2024-09-23 6:00 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $27.65 | $152,086 | 103,253 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 9:19 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $27.54 | $231,175 | 185,450 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:16 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
568 | $26.18 | $14,870 | 296,286 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:14 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
637 | $26.18 | $16,677 | 75,294 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:13 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
639 | $26.18 | $16,729 | 41,152 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:11 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
537 | $26.18 | $14,059 | 180,705 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:10 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,738 | $26.18 | $45,501 | 605,417 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.72 | $133,588 | 296,854 (Indirect Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:05 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $27.61 | $26,206 | 94,646 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-29 4:30 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
98,334 | $27.02 | $2,657,250 | 231,289 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-28 11:11 am |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $27.52 | $386,714 | 120,459 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 9:32 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.75 | $133,756 | 301,854 (Indirect Direct) |
View |
| 2024-07-23 Sale |
2024-07-25 5:54 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $27.07 | $4,381,867 | 323,431 (Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 9:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
34,811 | $28.04 | $976,274 | 236,317 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-02 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $23.4 | $117,020 | 306,854 (Indirect Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:13 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,516 | $22.64 | $56,965 | 310,790 (Indirect Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:11 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
2,825 | $22.64 | $63,961 | 74,867 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:09 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
2,831 | $22.64 | $64,094 | 46,799 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:06 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,380 | $22.64 | $53,886 | 180,178 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:04 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
569 | $22.64 | $12,883 | 18,562 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:01 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
7,894 | $22.64 | $178,728 | 581,553 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-02 Exercise |
2024-12-04 7:36 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 716,446 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 7:36 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $21.1 | 716,446 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 9:57 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $0 | 127,579 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 9:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $21.1 | 127,579 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 5:06 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0 | 91,007 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 5:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0.615 | 91,007 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $0 | 276,286 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $21.09 | 276,286 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:00 am |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $0 | 904,561 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:00 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $21.1 | 904,561 (Direct) |
View |
| 2024-10-30 Exercise |
2024-11-01 8:59 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $0 | 173,205 (Direct) |
View |
| 2024-10-30 Exercise |
2024-11-01 8:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $21.1 | 173,205 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-18 8:57 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $0 | 1,016,725 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-18 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $21.1 | 1,016,725 (Direct) |
View |
| 2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $0 | 327,002 (Direct) |
View |
| 2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $21.09 | 327,002 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 8:06 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
19,825 | $0 | 114,897 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 8:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
19,825 | $0.615 | 114,897 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-23 6:00 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $0 | 103,253 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-23 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $0.615 | 103,253 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 9:19 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $0 | 185,450 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 9:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $0.615 | 185,450 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:05 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $0 | 94,646 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
949 | $0.615 | 94,646 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
98,334 | $0 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
41,291 | $21.09 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,671 | $7.009 | 231,289 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-29 4:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
24,372 | $19.87 | 231,289 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-28 11:11 am |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $0 | 120,459 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-28 11:11 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
14,051 | $0.615 | 120,459 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 11:45 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
24,538 | $0 | 607,155 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 11:45 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
24,538 | $0.615 | 607,155 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 5:54 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $0 | 323,431 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 5:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
161,855 | $7.009 | 323,431 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 9:41 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,803 | $0 | 236,317 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 9:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,803 | $7.009 | 236,317 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,064 | $19.94 | 181,242 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,064 | $19.94 | 75,931 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
221 | $19.94 | 18,783 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,064 | $19.94 | 582,617 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,064 | $19.94 | 306,854 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:31 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
26,000 | $0 | 26,000 (Direct) |
View |